Relative faecal abundance of extended-spectrum β-lactamase-producing Enterobacterales and its impact on infections among intensive care unit patients: a pilot study

J Hosp Infect. 2021 Jun:112:92-95. doi: 10.1016/j.jhin.2021.03.022. Epub 2021 Mar 29.

Abstract

This pilot prospective study assessed the association between the faecal relative abundance of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) and the occurrence of ESBL-PE related infections. Twenty-four patients were included. The median ESBL relative abundance was 32.4%. The mean ESBL-PE relative abundance (ESBL-PE-RA) was more than five-fold higher in patients exposed during the last three months to antibiotics (P = 0.002). Furthermore, the mean ESBL relative abundance was more than two-fold higher in patients colonized with non-E. coli strains (P = 0.044). The mean ESBL-PE-RA was more than 10-fold higher for the concordant patients than for the discordant patients (59.1% vs 4.9%; P < 0.001).

Keywords: Antibiotic stewardship; Antimicrobial resistance; Enterobacterales; Extended-spectrum β-lactamase (ESBL); Relative faecal abundance.

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Feces
  • Humans
  • Intensive Care Units
  • Pilot Projects
  • Prospective Studies
  • beta-Lactamases*

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases